Comprehensive meta-analysis in the small cell lung cancer database (https://lce.biohpc.swmed.edu/lungcancer) showed that FADD was significantly elevated in tumor tissues (Figure 2G) and was an unfavorable prognostic indicator for OS in lung adenocarcinoma patients (Figure 2H). This evidence concerns the gene FADD and neoplasm.